Refined USP25/28 inhibitors with enhanced selectivity towards c-Myc driven squamous lung cancer cells
Adán Pinto-Fernández, Claire Heride, A.P. Turnbull, Dora C. S. Pedroso, Victoria Smith, Lisa Mullee, Wojciech W. Krajewski, Cameron Bell, Anthony C. Varca, Thomas M. Charlton, Dylan T. Jones, Tom E. McAllister, Roman Fischer, Elena Navarro‐Guerrero, Daniel V. Ebner, , Benedikt Mathias Kessler
This study develops refined USP25/28 inhibitors that selectively target c-MYC driven squamous lung cancer cells with reduced off-target effects and toxicity.
bioRxiv · Jun 18, 2026 · PreprintCancer Biology